Articles tagged with Covid 19
Primary care teams struggle to implement quality improvement efforts due to staff turnover, staffing shortages, and time constraints exacerbated by the COVID-19 pandemic. Researchers recommend direct support for primary care to alleviate burnout and improve participation in quality improvement projects.
A qualitative study found that staff turnover, staffing shortages, and time constraints are major barriers to participation in quality improvement projects. The authors recommend policy makers provide direct support for primary care to alleviate burnout and address these challenges.
A new vaccine candidate has shown protection against a range of coronaviruses, including current and future variants, by targeting the critical regions of the virus that it needs to complete its life cycle. The vaccine technology, developed at the University of Cambridge, aims to provide broad-based protection against emerging viruses.
Researchers found that overly broad definitions and lack of comparator groups have distorted the true risk of long COVID. This has led to increased public anxiety, healthcare spend, misdiagnoses, and diversion of funds from those with other long-term conditions.
A study led by IBEC analyzed cough sounds in COVID-19 patients to identify the severity of the disease. The research found that acoustic features of coughs could categorize patients as mild, moderate, or severe, enabling early intervention and remote monitoring.
A study published in Radiology: Cardiothoracic Imaging found that low- and middle-income countries reported persistent declines in cardiothoracic imaging procedure volumes after the COVID-19 pandemic. In contrast, high-income countries, including the US, recovered to pre-pandemic levels by 2021.
The Intergovernmental Negotiating Body Bureau emphasizes the importance of social media regulation and digital health literacy in managing infodemics, which can spread false information on public health matters. Effective infodemic management is seen as a critical component of the Pandemic Accord to safeguard lives worldwide.
Researchers discovered a convergence in potent suppression of interferon-stimulated genes through several viral proteins, including Orf6 and Orf9b, which serve as innate immune antagonist proteins. These findings provide potential new ways to address viral pandemics by targeting a common pathway that the virus uses for infectivity.
The study found that type 1 diabetes incidence slightly increased overall, while type 2 diabetes significantly increased after the COVID-19 pandemic. Non-Hispanic Black and Hispanic youth were disproportionately affected.
Operation Mercury successfully halted most illegal gold mining activity in La Pampa, Peru, reducing deforestation and water quality issues. However, spillover effects led to increased mining in legal areas, highlighting the need for stronger regulations to mitigate environmental harm.
A study of 68,000 patients with COVID-19 found that using Paxlovid or Lagevrio significantly reduced mortality and hospitalization rates in those at high risk of progressing to severe COVID-19, regardless of age, race, or virus strain. These medications can be used to treat non-hospitalized patients at high risk of severe disease.
A new study found that older adults with COPD had a heightened risk of depression during the early stages of the COVID-19 pandemic. Approximately 1 in 2 individuals with COPD and a pre-pandemic history of depression experienced a recurrence of depression.
Doctors who contracted long covid while working are struggling to access support and financial aid due to inadequate workplace protection. The condition affects up to 4.41% of healthcare workers, with nearly half losing income, and many facing dismissal or early retirement.
The Mount Sinai Hospital's Cohen Center will expand its research and clinical care to include 'long Lyme Disease/Lyme+', exploring key similarities and differences with long COVID. The center will offer novel therapies, including virtual reality and non-invasive brain stimulation technologies, as well as personalized cognitive rehabili...
A new analysis of COVID-19 cases in Africa found that the rate of infection was likely much higher than reported in the initial stages. The researchers estimated that approximately 66% of all infections were asymptomatic, while about 5% were severe and 27% were mild.
The UMass Amherst-UT Austin team has been awarded $27.5 million by the CDC to establish the nation's first disease outbreak response and modeling network. The $250 million program will support decision makers during public health emergencies like COVID-19.
A study found sociodemographic-based disparities in COVID-19 therapeutic drug availability, revealing gaps in treatment access. The research highlights the need for targeted interventions to address these disparities.
A recent clinical trial found that creatine supplementation significantly reduced post-COVID-19 fatigue and improved related symptoms such as loss of taste and breathing difficulties. Creatine levels in leg muscles and the brain also increased after 6 months of intake.
A nationwide study found that early treatment with plasma from recovered COVID patients can reduce the risk of developing post-COVID conditions. The research also suggests that elevated cytokine levels, particularly interleukin-6, may contribute to long COVID symptoms.
The AAO-HNSF 2023 Annual Meeting & OTO Experience will feature groundbreaking clinical research and professional development emerging within otolaryngology. The meeting will showcase the latest scientific oral presentations on various topics, including Otology, Laryngology, Endocrine Surgery, and more.
A 10-state study from the CDC's VISION Network identified risk factors for critical COVID-19 outcomes in adults hospitalized with the virus. Adults with four or more underlying disease risk factors, including hypertension, diabetes, heart disease, and obesity, are at higher risk of ICU admission and death.
A systematic review and meta-analysis found that rehabilitation interventions significantly improve functional exercise capacity, dyspnea, and quality of life in adults with post-COVID-19 condition. The certainty of evidence for these outcomes was moderate to high.
Rutgers researchers have developed a method to detect the early onset of deadly infectious diseases using a test that can flag 'quiet infected' patients who don't exhibit symptoms. The ultra-sensitive biosensor combines nanoballs and advanced electronics to detect viral nucleic acid material, enabling early infection detection.
Researchers identified a link between SARS-CoV-2 infection and Alzheimer's disease-like cognitive symptoms, triggered by Tau protein hyperphosphorylation. The study found increased Tau levels in infected cells, indicating pathological alterations to the protein.
The COVID-19 pandemic led to a significant increase in emergency department visits and hospitalizations for self-harm and suicidal ideation among adolescents, particularly young female adolescents. The disruptions of the pandemic may have contributed to this trend.
The American College of Physicians has issued updated rapid, living practice points on treating COVID-19 patients in outpatient settings. The new guidance supports the use of molnupiravir or nirmatrelvir-ritonavir for symptomatic patients with confirmed mild to moderate COVID-19.
A study at the Technical University of Munich found that people with long Covid experience altered blood vessels in the eye, which could be used to diagnose the condition. Persistent inflammatory responses were also linked to symptom severity and chronic inflammation.
The September issue of the CHEST journal features research on long COVID, including a review on exercise pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2. Original studies also explore asthma treatment with albuterol-budesonide inhalers and sleep therapy using oronasal masks.
Researchers discovered a gene called FOXM1 that plays a crucial role in repairing blood vessels and improving survival rates. A low-dose repurposed drug, decitabine, was found to reactivate the gene and promote vascular repair in aged mice. An alternative approach using endothelium-targeted nanoparticle gene delivery also showed promise.
A systematic review and meta-analysis of 195 clinical trials found that cell therapy can reduce the risk of death from COVID-19 by 60%. The studies, conducted in 30 countries between January 2020 and December 2021, used various types of cells, including mesenchymal stem cells and natural killer cells.
A new study by UCSF researchers has found that people who use both cannabis and tobacco have significantly higher rates of depression and anxiety than those who use either substance alone or not at all. The study analyzed data from 53,843 Americans and found that among dual users, 26.5% reported anxiety and 28.3% reported depression.
A cancer drug, idronoxil, has been shown to reduce inflammation caused by COVID-19, according to research published in Nature Communications. The study found that idronoxil can target specific inflammatory pathways, limiting the damage without increasing viral replication.
Receiving two doses of BNT162b2 vaccine was associated with lower risk of COVID-19 emergency department and outpatient visits. The risk appeared lower for those with two versus three doses, despite Omicron sublineages becoming dominant.
A majority of pharmacists in Sweden experienced increased workloads and a deteriorating work environment due to customer conflicts and new tasks. Despite this, many reported no impact on patient safety, highlighting the need for further research.
Researchers at George Washington University found that Facebook's core design features undermine its policies aimed at removing Covid-19 vaccine misinformation. The platform's architecture, designed to build communities around shared interests, can inadvertently facilitate the spread of misinformation.
A new SARS-CoV-2 variant Eris has been detected, showing an advantage in evading neutralizing antibodies and increasing infectivity. The study found that Eris is less effectively neutralized by antibodies present in the blood of vaccinated individuals or those with a previous infection.
Researchers at EMBL Grenoble have obtained the first structure of p38α being activated by MKK6, opening up new directions for developing drugs to stop cytokine storms. The inflammatory response is triggered by a series of kinases, and inactivating p38α could prevent inflammation from occurring.
A new study suggests that people who bought firearms during the height of the COVID-19 pandemic have higher rates of recent suicidal thoughts, self-harm behaviors, and intimate partner violence compared to other firearm owners and non-gun owners. Pandemic firearm buyers also tend to hold extreme beliefs, including anti-vaccination view...
A recent study published in the International Journal of Infectious Diseases found that individuals infected with the Omicron variant have a significantly lower risk of developing long COVID compared to those infected with earlier variants. The study analyzed data from over 11,000 people and found that around half of all wild-type infe...
A study of 3,500 traffic sensors in California found that rush hour is expanding but with less congestion after the COVID-19 pandemic. Researchers attribute this shift to changes in commuting patterns and road usage.
Researchers at University of California - Riverside uncover COVID's Achilles heel - its dependence on key human proteins. By understanding how the virus interacts with human cells, a new class of antiviral medication may be developed to block replication and treatment.
A study of 300,000 sepsis admissions found that the condition is more prevalent than previously thought, but many patients survive. The observed increase in cases is largely due to more people developing sepsis repeatedly, rather than dying the first time they contract it.
A study published in NPJ Aging reveals that COVID-19 exacerbates production of auto-antibodies associated with blood clotting disorders and aging. Researchers found that severe COVID-19 cases display a significant age-related increase in auto-antibodies, which can lead to tissue injury and organ damage.
The Mount Sinai Hospital received a $13 million NIH grant to create vaccines that can protect against various types of coronaviruses. The project aims to develop variant-proof, universal vaccines that offer broad protection against existing and future SARS-CoV-2 variants, pandemic, zoonotic, and seasonal coronaviruses.
The study found significant reductions in breast cancer screening volume and uptake globally during the 2020 COVID-19 pandemic. The analysis of 26 studies from 13 countries revealed a decline in screening volumes ranging from 13% to 61%, and screening uptake rates varying by up to 43.5%.
A first-of-its-kind study by LSU Health New Orleans found that chronic diseases, such as hypertension and diabetes, explained nearly two-fifths of the racial disparity in COVID-associated hospitalizations. Non-Hispanic Black cancer patients had a higher prevalence of chronic diseases and were more than twice as likely to live in high-p...
A study of 50,000 COVID-19 cases found that immunity following infection provides better protection against transmission than vaccination, but only for a short period. Vaccination reduces contagiousness over a longer time, making it essential to consider simple public health measures like air filtration and mask-wearing.
A recent NIH study found that caregiver pandemic-related stress was associated with increased child behavior problems, while higher levels of emotional and instrumental support reduced these issues. The research suggests that support for caregivers positively impacted child behavior outcomes across diverse racial and ethnic backgrounds.
Researchers at UTSA are studying the bioactive properties of Sweet Annie, a plant used in traditional Chinese medicine for over 2,000 years. The study reveals that arteannuin B from the plant has anti-COVID and anti-glioblastoma properties, offering new avenues for targeted therapy.
A study of health care workers found that co-administering COVID-19 and influenza vaccines was not associated with reduced immune response or increased adverse events. The results support the co-administration of these vaccines, suggesting a safer and more efficient vaccination strategy.
A new editorial paper explores the effectiveness of the third dose booster vaccine against SARS-CoV-2 in immunocompromised individuals. Researchers found that while the vaccine improves vaccine effectiveness across various measures, its benefits are not as significant for patients with cancer.
A new study by Uppsala University researchers reveals a significant difference in vaccination rates among people with varying cognitive abilities. Among those with the highest cognitive ability, 80% were vaccinated within 50 days, while it took 180 days for those with the lowest cognitive ability to reach the same rate.
A new study published in Cancer Management and Research found that 1 in 8 older adults with a history of cancer experienced depression for the first time during the early stages of the pandemic. Those with functional limitations, family conflict, and women were particularly vulnerable to depression.
A study from Amsterdam UMC followed over 250 elite athletes who had contracted COVID-19 and found no severe heart issues impacting their careers. Despite some athletes showing slightly elevated resting heart rates, there were no significant differences in overall heart function or ventricular arrhythmias.
Researchers developed a long-lasting skin coating agent that kills pathogens on the hands, boosting the natural hand barrier. The agent retained high antimicrobial activity even two hours after application, and reduced survival time of coronaviruses and influenza viruses.
A study published in Nature has identified 51 significant genome-wide loci associated with COVID-19 severity and SARS-CoV-2 susceptibility. The research adds 28 new loci to the list, providing valuable information about three key biological pathways involved in determining disease outcomes.
Researchers found decreased in situ and invasive melanoma diagnoses during the pandemic, which may reflect reduced skin cancer screening. Thick melanomas increased primarily due to a decrease in thin melanomas, rather than an absolute increase in thicker ones.
The study presents a pioneering detection tool that combines molecular biology and electronics to identify various pathogenic agents. The technology has demonstrated remarkable sensitivity detecting as few as 10 target molecules and rapid results under one hour.
A study by Mass General Brigham researchers found that patients with rheumatic diseases who developed long COVID were more likely to have expanded, pro-inflammatory antibodies specific to a coronavirus that causes the common cold. The team identified OC43 as a potential biomarker for long COVID.
A new study assesses COVID-19's impact on ED visits in BC, revealing a 42% reduction in respiratory issues and 35% drop in mental health concerns during the pandemic. Visits returned to pre-pandemic levels in May 2021, with some areas experiencing higher volumes due to heat-related overdoses.